Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bruker Introduces Novel AVANCE III HD NMR Spectrometer

Published: Monday, July 09, 2012
Last Updated: Monday, July 09, 2012
Bookmark and Share
The new AVANCE III HD is the Ultimate NMR platform for life science and materials research, as well as a robust, automated and easy-to-use analysis system for pharma/biotech, chemistry, metabolomics, nutritional science and molecular diagnostics research.

At the Experimental Nuclear Magnetic Resonance Conference (ENC) 2012, Bruker has introduced the novel AVANCE III HD NMR spectrometer.

Thanks to its new digital RF synthesizer, further enhanced receiver electronics, redesigned preamplifiers, extended Digital Lock™ and SmartVT™ capabilities, Bruker now has further enhanced the most sensitive and most accurate, highest performance NMR spectrometer on the market, bringing High Definition (HD) technology to AVANCE NMR users.

The AVANCE III HD spectrometer benefits from a next-generation RF synthesizer with significantly increased digital integration, incorporating a lower phase noise local oscillator (LO) and a high speed DA converter running at 960 MHz.

This enables extended digital RF power settings up to NMR frequencies of 1.2 GHz.

Together with the new high dynamic range and high sensitivity preamplifiers, the AVANCE III HD demonstrates improved spectral purity, fully exploits the increased sensitivity of the latest NMR probe technology and enables sensitivity improvements of up to 30% for the most demanding applications.

These include experiments on bio-molecular samples in buffers or detergents, metabolic beverage analysis for food safety and quality, and trace analysis such as impurity detection in drugs and other pharmaceutical compounds.

With the new AVANCE III HD preamplifiers and the new GaAs FET-based broad-band technology, solid-state NMR applications in particular will directly benefit from up to a 20% increase in sensitivity on 13C and other X nuclei.

A novel impedance matching technology ensures solids spectra with excellent symmetry, and the active, fast high power transmit/receive switch guarantees maximum linearity even at the lowest power levels.

The AVANCE III HD now provides solid-state NMR researchers with access to fully broad-banded capacities and easier daily routine operation without the need for manual interaction.

A touch-screen display enables high-definition tuning and matching of the system and monitoring of the probe status.

With the revolutionary NMR Thermometer™ for the first time, the measurement of the exact internal sample temperature by NMR itself is possible.

This is achieved fully automatically through the measurement of the chemical shift difference between two deuterium resonances, rather than relying on inaccurate external thermocouples.

While one deuterium signal is used for field stabilization, the chemical shift difference to the second signal is used together with the SmartVT™ to both measure and maintain a constant temperature within the sample.

Based on the measurement of the actual sample temperature, the NMR Thermometer™ now offers the possibility of up to 50% times faster on-line regulation of sample temperature, more efficient compensation for heating effects caused by RF pulse sequences, or by sample spinning in MAS experiments.

This results in an immediate improvement in the accuracy and precision of the acquired signal frequencies by up to a factor 5, delivering improved accuracy in the assignment of resonances, especially in solid-state, and 2D/3D/4D protein and biomolecular NMR applications.

"With our unsurpassed commitment to innovation and to bringing the latest technology to the field of NMR, the new AVANCE III HD spectrometer once again offers enabling R&D innovations and performance breakthroughs from our R&D centers and key customer collaborations to all NMR customers," said Dr. Frank Laukien, Bruker's President and CEO.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PREMIER Biosoft Announces Reseller Agreement with Bruker
Agreement aims to advance lipidomics and metabolomics research.
Monday, November 17, 2014
Bruker Reports 7% Revenue Growth in Q4
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
Wednesday, February 19, 2014
Novel Approach for Inborn Errors of Metabolism Screening by NMR
Clinical IEM-by-NMR screening study in Turkey measures 65 metabolites in urine simultaneously, including 20 endogeneous metabolites and 45 metabolites associated with inborn errors of metabolism.
Wednesday, September 04, 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Self-Assembling, Biomimetic Membranes May Aid Water Filtration
A synthetic membrane that self assembles and is easily produced may lead to better gas separation, water purification, drug delivery and DNA recognition, according to an international team of researchers.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Can Cell Cycle Protein Prevent or Kill Breast Cancer Tumors?
An MD Anderson study has shown the potential of a simple molecule involved in cancer metabolism as a powerful therapeutic.
Study Reveals Improved Way to Interpret High-Throughput Biological Data
A recent study has revealed a novel workflow, identifying associations between molecules to provide insights into cellular metabolism and gene expression in complex biological systems.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Researchers Link Liver Disease and Drug Metabolism
Researchers have discovered that nonalcoholic steatohepatitis, an increasingly common but often undiagnosed liver disease, could have significant medical implications for people with type 2 diabetes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!